T-cell Immunotherapies and the Role of Nonclinical Assessment: The Balance between Efficacy and Pathology.
about
T-cell Immunotherapies and the Role of Nonclinical Assessment: The Balance between Efficacy and Pathology.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
T-cell Immunotherapies and the ...... etween Efficacy and Pathology.
@en
T-cell Immunotherapies and the ...... etween Efficacy and Pathology.
@nl
type
label
T-cell Immunotherapies and the ...... etween Efficacy and Pathology.
@en
T-cell Immunotherapies and the ...... etween Efficacy and Pathology.
@nl
prefLabel
T-cell Immunotherapies and the ...... etween Efficacy and Pathology.
@en
T-cell Immunotherapies and the ...... etween Efficacy and Pathology.
@nl
P2860
P921
P356
P1476
T-cell Immunotherapies and the ...... between Efficacy and Pathology
@en
P2093
Michaela E Sharpe
P2860
P304
P356
10.1177/0192623317752101
P407
P5008
P577
2018-02-01T00:00:00Z